The Product:
The ZRO® is a non-incisional, transcervical female sterilization device.
The Market:
The market potential for
minimally invasive sterilization devices is over 2,000,000
in the U.S.
Investors:
Company established to develop and market its proprietary, non-incision tubal ligation/ contraceptive device, the ZRO®.
Mission Statement
Operculum will deliver implantable women’s permanent contraception devices with only the highest efficacy, giving them effortless control of their reproductive systems, at the lowest possible cost and using the safest and simplest medical procedures.
This device is not FDA approved. Not for sale in the U.S.